PHARMACEUTICALS
Israel is home to companies and commercialization organizations throughout the entire medical value chain – from development to manufacturing.
According to Israel Export and International Cooperation Institute (IEICI), pharmaceutical product exports from Israel in 2016 reached $6.9 billion, an increase of 1.5% compared to 2015. pharmaceuticals provided a significant part, about 30%, of overall industrial high-tech exports.
1. RESEARCH AND DEVELOPMENT
Israeli academia is heavily involved in the life sciences industry and the pharmaceuticals segment, and commercialization companies play an important role in this process.
2. PRODUCTION
Generics – half of the pharmaceutical companies in Israel develop generic drugs. Leading Israeli companies in the field include Dexcel, Unipharm and Teva.
Teva Pharmaceutical Industries is the largest life sciences company in Israel and the largest generics company in the world. Teva develops, manufactures and markets its products worldwide. The company's business includes a wide range of chemical, biological, generic and biogeneric compounds. Company sales in 2015 totaled $19.5 billion and the company employed 42,888 people.
Original drugs – There are several original drug manufacturers in Israel, including Enzymotec, which develops and manufactures therapeutic compounds, and Protalix, which develops and markets biological compounds.
3. MARKETING AND DISTRIBUTION
Drugs in Israel are imported, marketed and distributed by Israeli companies and by international ones that have established branches in Israel for this purpose.
There are several Israeli pharmaceutical companies such as Neopharm Israel and Lapidot Medical of the Lapidot Group.
Many MNCs in Israel engage in various fields of business, including marketing and distribution. Novartis Israel is a part of the giant global pharmaceutical corporation and employs approximately 180 people in Israel. The company markets and sells various types of drugs, and is responsible for advancing many studies.
